Monitoring response and resistance to the novel arsenical darinaparsin in an AML patient
Acute myeloid leukemia (AML) with inversion of chromosome 3 is characterized by overexpression of EVI1 and carries a dismal prognosis. Arsenic-containing compounds have been described to be efficacious in malignancies overexpressing EVI1. Here we describe a case of AML with inv(3)(q21q26.2) treated...
Saved in:
Main Authors: | Torsten Holm eNielsen (Author), Nathalie eJohnson (Author), Nicolas eGarnier (Author), Stanley eKwan (Author), Lu eYao (Author), Eftihia eCocolakis (Author), Josée eHébert (Author), Robert A. Morgan (Author), Éric ePaquet (Author), Kevin P. Callahan (Author), Craig T. Jordan (Author), Sarit eAssouline (Author), Wilson H. Miller (Author), Koren K. Mann (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2013-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic Cancer Therapy:
by: Michael Ostario Palumbo, et al.
Published: (2013) -
MicroRNA-mRNA Pairs Associated with Outcome in AML: From in vitro Cell-based Studies to AML Patients
by: Neha S Bhise, et al.
Published: (2016) -
p53 biology and reactivation for improved therapy in MDS and AML
by: Joanna E. Zawacka
Published: (2024) -
Protein Kinase C-δ Mediates Shedding of Angiotensin-Converting Enzyme 2 from Proximal Tubular Cells
by: Fengxia eXiao, et al.
Published: (2016) -
Polyphenols from the mangosteen (Garcinia mangostana) fruit for breast and prostate cancer
by: Gongbo eLi, et al.
Published: (2013)